CFLAR and hepatocellular carcinoma: Finally, Chen et al. investigated the role of miR-382 in sensitizing HCC cells to the antitumor effects of γδ T cells by targeting the expression of cellular FADD-like interleukin-1b-converting enzyme-inhibitory protein (c-FLIP) [82].